Literature DB >> 19956460

Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation.

Chiara Ruffini1, Marco Locatelli, Adelio Lucca, Francesco Benedetti, Chiara Insacco, Enrico Smeraldi.   

Abstract

BACKGROUND: The orbitofrontal cortex (OFC) plays a major role in the pathophysiology of obsessive-compulsive disorder (OCD); functional neuroimaging studies indicate that OCD symptoms are associated with increased activity in the OFC, caudate nucleus, thalamus, and anterior cingulate gyrus. The goal of our single-blind study was to assess whether repetitive transcranial magnetic stimulation (rTMS) over the left OFC would influence OCD symptoms in drug-resistant patients.
METHOD: Twenty-three consecutively admitted right-handed inpatients with DSM-IV-TR-diagnosed drug-resistant OCD were given rTMS (80% motor threshold, 1 Hz seconds per minute for 10 minutes every day for 15 days) to the left OFC parallel (active: n = 16) or perpendicular (sham: n = 7) to the scalp. The patients' OCD symptoms, mood, and anxiety were rated at baseline, at the end of treatment, and once every 2 weeks for 3 months after treatment. Data were gathered from June 2006 to November 2007.
RESULTS: Considering changes in Yale-Brown Obsessive Compulsive Scale (YBOCS) scores with 2-way analysis of variance for repeated measures for a total of 8 observations (before rTMS, after treatment, and every 2 weeks for 12 weeks' follow-up), we found significant reduction of YBOCS scores comparing active versus sham treatment for 10 weeks after the end of rTMS (P < .02), with loss of significance after 12 weeks (P < .06). We also found a reduction of anxiety and depression symptoms but not a significant difference in the 2 groups.
CONCLUSIONS: Low-frequency rTMS of the left OFC produced significant but time-limited improvement in OCD patients compared to sham treatment.

Entities:  

Year:  2009        PMID: 19956460      PMCID: PMC2781034          DOI: 10.4088/PCC.08m00663

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  32 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method.

Authors:  S Pridmore; J A Fernandes Filho; Z Nahas; C Liberatos; M S George
Journal:  J ECT       Date:  1998-03       Impact factor: 3.635

3.  Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996.

Authors:  E M Wassermann
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-01

4.  Drug therapy and cerebral perfusion in obsessive-compulsive disorder.

Authors:  V Molina; R Montz; M Martín-Loeches; A Jiménez-Vicioso; J L Carreras; F J Rubia
Journal:  J Nucl Med       Date:  1995-12       Impact factor: 10.057

5.  Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study.

Authors:  B D Greenberg; M S George; J D Martin; J Benjamin; T E Schlaepfer; M Altemus; E M Wassermann; R M Post; D L Murphy
Journal:  Am J Psychiatry       Date:  1997-06       Impact factor: 18.112

6.  Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.

Authors:  R T Rubin; J Ananth; J Villanueva-Meyer; P G Trajmar; I Mena
Journal:  Biol Psychiatry       Date:  1995-10-01       Impact factor: 13.382

7.  Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.

Authors:  L R Baxter; J M Schwartz; J C Mazziotta; M E Phelps; J J Pahl; B H Guze; L Fairbanks
Journal:  Am J Psychiatry       Date:  1988-12       Impact factor: 18.112

8.  Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.

Authors:  R T Rubin; J Villanueva-Meyer; J Ananth; P G Trajmar; I Mena
Journal:  Arch Gen Psychiatry       Date:  1992-09

9.  The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group.

Authors:  M M Weissman; R C Bland; G J Canino; S Greenwald; H G Hwu; C K Lee; S C Newman; M A Oakley-Browne; M Rubio-Stipec; P J Wickramaratne
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

10.  Random allocation software for parallel group randomized trials.

Authors:  Mahmood Saghaei
Journal:  BMC Med Res Methodol       Date:  2004-11-09       Impact factor: 4.615

View more
  38 in total

Review 1.  Neuromodulation for obsessive-compulsive disorder.

Authors:  Kyle A B Lapidus; Emily R Stern; Heather A Berlin; Wayne K Goodman
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

2.  Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases.

Authors:  Michael D Fox; Randy L Buckner; Hesheng Liu; M Mallar Chakravarty; Andres M Lozano; Alvaro Pascual-Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 3.  Transcranial cortical stimulation in the treatment of obsessive-compulsive disorders: efficacy studies.

Authors:  Ghassen Saba; Albert Moukheiber; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

Review 4.  A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Simone Rehn; Guy D Eslick; Vlasios Brakoulias
Journal:  Psychiatr Q       Date:  2018-09

Review 5.  Review of structural neuroimaging in patients with refractory obsessive-compulsive disorder.

Authors:  Murad Atmaca
Journal:  Neurosci Bull       Date:  2011-06       Impact factor: 5.203

Review 6.  [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].

Authors:  A Kordon; B Zurowski; K Wahl; F Hohagen
Journal:  Nervenarzt       Date:  2011-03       Impact factor: 1.214

7.  Invasive and Non-invasive Neurostimulation for OCD.

Authors:  Isidoor O Bergfeld; Eva Dijkstra; Ilse Graat; Pelle de Koning; Bastijn J G van den Boom; Tara Arbab; Nienke Vulink; Damiaan Denys; Ingo Willuhn; Roel J T Mocking
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 8.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

9.  Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders.

Authors:  Lisa M McTeague; Benjamin M Rosenberg; James W Lopez; David M Carreon; Julia Huemer; Ying Jiang; Christina F Chick; Simon B Eickhoff; Amit Etkin
Journal:  Am J Psychiatry       Date:  2020-01-22       Impact factor: 18.112

Review 10.  Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD): A Review.

Authors:  Belen Rubio; Aaron D Boes; Simon Laganiere; Alexander Rotenberg; Danique Jeurissen; Alvaro Pascual-Leone
Journal:  J Child Neurol       Date:  2015-12-10       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.